Cartilage intermediate layer protein affects the progression of intervertebral disc degeneration by regulating the extracellular microenvironment (Review)
Authors:
Open Access
- 24 December 2020
- journal article
- review article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 47 (2) , 475-484
Abstract
Intervertebral disc degeneration (IDD), which is caused by multiple factors, affects the health of individuals and contributes to low back pain. The pathology of IDD is complicated, and changes in the extracellular microenvironment play an important role in promoting the process of degeneration. Cartilage intermediate layer protein (CILP) is a matrix protein that resides in the middle of human articular cartilage and is involved in numerous diseases that affect cartilage. However, there is no detailed review of the relationship between CILP and degenerative disc disease. Growing evidence has revealed the presence of CILP in the extracellular microenvironment of intervertebral discs (IVDs) and has suggested that there is a gradual increase in CILP in degenerative discs. Specifically, CILP plays an important role in regulating the metabolism of the extracellular matrix (ECM), an important component of the extracellular microenvironment. CILP can combine with transforming growth factor‑β or insulin‑like growth factor‑1 to regulate the ECM synthesis of IVDs and influence the balance of ECM metabolism, which leads to changes in the extracellular microenvironment to promote the process of IDD. It may be possible to show the correlation of CILP with IDD and to target CILP to interfere with IDD. For this purpose, in the present study, the current knowledge on CILP was summarized and a detailed description of CILP in discs was provided.Keywords
This publication has 82 references indexed in Scilit:
- Does Lumbar Disc Degeneration on Magnetic Resonance Imaging Associate With Low Back Symptom Severity in Young Finnish Adults?Spine, 2011
- Cartilage Intermediate Layer Protein 2 (CILP-2) Is Expressed in Articular and Meniscal Cartilage and Down-regulated in Experimental OsteoarthritisJournal of Biological Chemistry, 2011
- High throughput proteomic analysis of the secretome in an explant model of articular cartilage inflammationJournal of Proteomics, 2011
- Nucleus pulposus tissue engineering: a brief reviewEuropean Spine Journal, 2009
- Age-Related Changes in the Extracellular Matrix of Nucleus Pulposus and Anulus Fibrosus of Human Intervertebral DiscSpine, 2009
- The Twin Spine Study: Contributions to a changing view of disc degeneration†The Spine Journal, 2009
- The vertebral endplate: disc degeneration, disc regenerationEuropean Spine Journal, 2006
- The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilageArthritis & Rheumatism, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Recent advances in TGF-β effects on chondrocyte metabolismCytokine & Growth Factor Reviews, 2002